Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer Academic Article uri icon

Overview

MeSH Major

  • Fallopian Tube Neoplasms
  • Hemocyanin
  • Neoplasms, Glandular and Epithelial
  • Ovarian Neoplasms
  • Peritoneal Neoplasms
  • Saponins
  • Vaccines, Conjugate

abstract

  • This heptavalent-KLH conjugate plus QS21 vaccine safely induced antibody responses against five of seven antigens. Investigation in an adequately powered efficacy trial is warranted.

publication date

  • July 15, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-06-2949

PubMed ID

  • 17634545

Additional Document Info

start page

  • 4170

end page

  • 7

volume

  • 13

number

  • 14